Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enrollment begins in phase III trial of Leuprogel 4-month for prostate cancer

Jan. 30, 2001

Production, development of recombinant mammastatin planned by Biotherapies

Jan. 30, 2001

Oxford BioMedica and AHP jointly develop novel antibody cancer therapy

Jan. 30, 2001

PBOX-6 shows potential for bypassing apoptotic suppressor Bcr-Abl in CML

Jan. 30, 2001

Geron regains rights to telomerase inhibitors from Pharmacia; forms new division

Jan. 30, 2001

Somatostatin and neuromedin B receptor agonists and their use

Jan. 29, 2001

New isocoumarins with antiangiogenic activity claimed by Korean scientists

Jan. 29, 2001

Selective aromatase inhibitors show promise in early or preventive breast cancer treatment

Jan. 29, 2001

Apoptosis inducers emerge from R&D at Nippon Kayaku

Jan. 26, 2001

Neurim team discovers new melatonin-related compounds with unique profile

Jan. 26, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...